SCHEMBL9527610

SCHEMBL9527610

CCc1nc(-c2ccccc2)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 8/20 0.44
AGTR2 P50052 7/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RAB9A P51151 1/20 0.43
NR1H3 Q13133 3/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
NR1H2 P55055 2/20 0.40
TDP2 O95551 1/20 0.39
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529156 0.92 AGTR2 (0.49) AGTR1AGTR2SMN1; SMN2NPC1CYP1A2
SCHEMBL6008041 0.90 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9699511 0.89 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL9527936 0.89 AGTR1 (0.46) AGTR1AGTR2SMN1; SMN2NPC1CYP1A2
SCHEMBL9528202 0.87 AGTR1 (0.50) AGTR1AGTR2
SCHEMBL9533095 0.87 SMN1; SMN2 (0.39) AGTR1AGTR2SMN1; SMN2NPC1CYP1A2
SCHEMBL9700539 0.87 SMN1; SMN2 (0.39) AGTR1AGTR2SMN1; SMN2NPC1CYP1A2
SCHEMBL9527391 0.87 AGTR1 (0.43) AGTR1AGTR2SMN1; SMN2NPC1CYP1A2
SCHEMBL9700543 0.87 SMN1; SMN2 (0.39) AGTR1AGTR2SMN1; SMN2NPC1CYP1A2
SCHEMBL6007769 0.86 AGTR1 (0.43) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed